Stabilized oxymetazoline formulations and their uses | Patent Number 10335391

US 10335391 B2
Application Number15984918
Publication NumberUS 20180263962 A1
Pendency1 year, 1 month, 12 days
Filled DateMay 21, 2018
Priority DateJun 11, 2014
Publication DateSep 20, 2018
Expiration DateJun 10, 2034
Inventor/ApplicantsSteven Zhang
Pramod Sarpotdar
Amy Kuang
Gurpreet Ahluwalia
Kevin Warner
ExaminesSHIAO, REI TSANG
Art Unit1629
Technology Center1600
Assignments
Epi Health Llc
Current
Aclaris Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.